ICOS Antikörper (C-Term)
Kurzübersicht für ICOS Antikörper (C-Term) (ABIN2287313)
Target
Alle ICOS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 156-185, C-Term
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- ICOS, CT (Inducible T cell Co-stimulator, Activation Inducible Lymphocyte Immunomediatory Molecule, AILIM, CD278, CD278 Antigen, MGC39850)
-
Aufreinigung
- Purified by Ammonium Sulfate Precipitation
-
Immunogen
- KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 156-185 in the C-terminal region of human ICOS, UniProt Accession #Q9Y6W8
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- ICOS (Inducible T-Cell Co-Stimulator (ICOS))
-
Andere Bezeichnung
- ICOS
-
NCBI Accession
- NP_036224
-
UniProt
- Q9Y6W8
-
Pathways
- Cancer Immune Checkpoints
Target
-